Please find below the links to all Direct Healthcare Professional Communications (DHPCs) issued in March 2019

Notice type: 3rd Party Publications

Date: 02/04/2019

Please find below the links to all Direct Healthcare Professional Communications (DHPCs) issued in March 2019 

Date: 28/03/2019

Genvoya, Stribild, Tybost (elvitegravir/cobicistat) - Important Safety Information from Gilead Sciences Ltd as approved by HPRA

Date: 28/03/2019

Xeljanz (tofacitinib) - Important Safety Information from Pfizer Healthcare Ireland as approved by HPRA


« Back